ALSTON & BIRD LLP lobbying for BIOMERIEUX, INC.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Utah · House · Senate · $30,000.00 income · posted Jul 21, 2025

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 6

Budget/Appropriations

H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.

Health Issues

Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).

Medical/Disease Research/Clinical Labs

Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).

Medicare/Medicaid

Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).

Trade (domestic/foreign)

Discussions regarding tariff proposals.

Taxation/Internal Revenue Code

H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code.